How is intrahepatic cholestasis diagnosed?

How to Diagnose Intrahepatic Cholestasis

Begin with abdominal ultrasound as the first-line imaging to exclude extrahepatic biliary obstruction; if no bile duct dilation is present, a diagnosis of intrahepatic cholestasis can be reasonably made, followed by serum antimitochondrial antibody (AMA) testing in adults with chronic disease. 1

Initial Diagnostic Algorithm

Step 1: Clinical Assessment

Look specifically for:

• Pruritus (itching) - the hallmark symptom
• Jaundice (may or may not be present)
• Duration of symptoms (chronic if >6 months)
• Drug history within 6 weeks of presentation (including herbal medicines, vitamins)
• Pregnancy status (second/third trimester)
• Family history of cholestatic liver disease
• Fever with rigors or right upper quadrant pain (suggests extrahepatic obstruction, not intrahepatic cholestasis)
• Prior biliary surgery (increases likelihood of obstruction) 1

Step 2: Laboratory Testing

Order these specific tests:

• Alkaline phosphatase (AP) - elevated >1.5× upper limit of normal
• Gamma-glutamyl transferase (GGT) - elevated >3× upper limit of normal
• Serum bile acids - diagnostic when elevated
• Aminotransferases (ALT, AST) - may be elevated
• Conjugated bilirubin - may be elevated 1

Critical caveat: Isolated GGT elevation has little specificity and may result from alcohol or drug-induced enzyme induction. Isolated AP elevation can occur in bone disease or pregnancy, not just cholestasis 1.

Step 3: Imaging to Exclude Extrahepatic Obstruction

Abdominal ultrasound is mandatory as the first imaging study 1. It differentiates intra- from extrahepatic cholestasis by detecting bile duct dilation.

If ultrasound shows NO bile duct dilation: Proceed to intrahepatic cholestasis workup (Step 4).

If ultrasound shows bile duct dilation or is equivocal:

• Consider MRCP (magnetic resonance cholangiopancreatography) as the next step - safer than ERCP 1
• Endoscopic ultrasound (EUS) is an alternative, particularly for distal biliary obstruction 1
• Avoid diagnostic ERCP unless therapeutic intervention is anticipated, given its complication rate (pancreatitis 3-5%, bleeding 2%, cholangitis 1%, mortality 0.4%) 1

Important: If clinical suspicion for extrahepatic cause remains high despite negative imaging (e.g., early pancreatic cancer), repeat ultrasound or pursue alternative imaging 1.

Step 4: Workup of Confirmed Intrahepatic Cholestasis

In Adults with Chronic Intrahepatic Cholestasis:

Test serum antimitochondrial antibodies (AMA) next 1:

• AMA positive (titer ≥1:40) with cholestatic enzyme profile = Primary Biliary Cirrhosis (PBC) diagnosis with >95% specificity 1
• AMA detected in >90% of PBC patients 1
• Consider anti-AMA-M2 (anti-PDC-E2) testing if available for increased sensitivity 1

If AMA and PBC-specific antinuclear antibodies (ANA) are negative:

• Proceed to MRCP at a specialized center 1
• If MRCP is unrevealing, perform liver biopsy 1

Liver Biopsy Requirements:

When diagnosis remains unclear after negative AMA and MRCP:

• Biopsy must contain ≥10 portal fields (due to high sampling variability in small bile duct disease) 1
• Classify findings into three categories:
  1. Disorders involving bile ducts: AMA-negative PBC, isolated small duct PSC, ABCB4 deficiency, sarcoidosis, idiopathic ductopenia, drug-induced cholestasis
  2. Disorders not involving bile ducts: Storage/infiltrative diseases, granulomas, nodular regenerative hyperplasia
  3. Hepatocellular cholestasis with minimal histologic changes: BRIC, drug-induced, sepsis, parenteral nutrition, paraneoplastic 1

Consider genetic testing for ABCB4 (canalicular phospholipid export pump) when available, especially if biopsy findings compatible with PBC or PSC but AMA negative 1

Special Population: Pregnancy (Intrahepatic Cholestasis of Pregnancy)

Diagnose based on:

• Pruritus in second/third trimester
• Serum bile acid level >10 μmol/L (can use non-fasting sample) 2, 3
• Measure bile acids AND liver transaminases in suspected cases 4
• Mild-moderate transaminase elevation (up to 10-20× ULN) with total bilirubin <6 mg/dL is typical 2

If bile acids are initially normal but suspicion remains high, repeat testing after excluding other causes (biliary obstruction, viral hepatitis, chronic liver disease) 2.

Common Pitfalls to Avoid

1. Don't perform diagnostic ERCP first - always start with ultrasound, then MRCP/EUS if needed 1
2. Don't skip AMA testing in adults - it's mandatory for chronic intrahepatic cholestasis workup 1
3. Don't accept inadequate liver biopsies - require ≥10 portal fields 1
4. Don't assume isolated GGT elevation means cholestasis - it lacks specificity 1
5. Don't stop investigating if imaging is negative but clinical suspicion is high - repeat imaging or consider early malignancy 1